Bio-Process Technology Market Growth Analysis, Industry Trends, And Forecast By 2023

 Overview:

The global bio-process technology market to experience significant growth during the forecast period (2017-2022), reports Market Research Future (MRFR) in an elaborate study. The technology allows the derivation of living cells or their components to utilize it in a vast array of treatments to attain the planned result. Healthcare sector has been experiencing some significant revamping owing to such advanced technology, and the market is touted to experience the benefits during the forecast period.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/2095 

Drivers and Restraints:

The spurring market has drivers in diverse sectors such as healthcare, food processing, biomedical devices, pollution, and global warming. In commercial biotechnology, it is used in the production of enzymes and antibiotics which is gaining traction continually. Vaccinations for several chronic diseases have also generated considerable demand for the technology.

Food processing is also a sector that is developing rapidly owing to changes made in lifestyle triggered by rapid urbanization and industrialization. Various nutritional supplements are the result of the introduction of such technology and are assisting the commoners in leading a healthier life.

The technology is also a possible answer for sustainable resource management. Wastewater management is an area where its impact is convincing, and it can work wonder in contaminated sites as well. Petroleum sector can also benefit much as the growing demand for biofuels can give the market essential momentum.

However, the regulatory process often delays the productional procedure which can be considered to be a market deterrent. But its multifarious application can help it maintain steady traction in the market.

Industry News:

In late 2017, Novartis’ Kymriah and Gilead/ Kite Pharma’s Yescarta, two cell-therapy biotherapeutic medicine got approved which came as excellent news to cell therapy which got significant boost from monoclonal antibody industry.  

Segmentation:

The global bio-process technology market can be segmented by type, application, and end-users.

Type-based segmentation includes cell culture, cell expansion, flow cytometry, cell line development and virus infiltration. Cell culture is a segment that is enjoying popularity across the world owing to its diverse application in various sectors. The segment is spearheading the market due to its necessity in treating multiple chronic diseases.

Application-wise, the market comprises biopharmaceuticals, specialty products, industrial chemicals and environment management aid. Biopharmaceuticals are prospering much as various medicines used in curing several diseases ranging from the most common ones to chronic diseases are products of such technological advancements. Furthermore, petrochemicals are going to boost the demand for industrial chemicals in the coming years.

Based on end-users, the market consists hospitals, research labs and centers, medical institutions and others. With increasing government and private funding, research labs and centers are extensively investing themselves in developing new products that can take various associated industries miles ahead.

Regional Analysis:

Region-wise, the market comprises namely North America, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).

North America is currently leading the market in terms of generating revenue. Academic researches and extensive sales of biopharmaceutical products are contributing much to the progress of the region. Well-developed manufacturing facilities and research laboratories in countries such as the U.S. and Canada are proving beneficial for the market.

The APAC is expected to become the fastest growing region during the forecast period. Rising population and the integration of advanced technologies in the healthcare sector are impacting the market significantly. The biotechnology industry is also expanding at a considerable rate.

Market Dashboard:

The market is growing competitive, and the companies are extending their portfolio by going into mergers and acquisitions. For instance, Charles River Laboratories has recently acquired MPI Research, a remarkable organization of this field. Thermo Fisher Scientific, Inc. recently signed an agreement with Roper Technologies to acquire Gatan.

Key players of the market profiled in this report are Merck Millipore (Germany), Thermo Fisher Scientific, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Danaher Corporation (U.S.), Lonza Group AG (Switzerland), Sartorius Stedim Biotech S.A (France), Corning, Inc.(U.S.), Bio-Rad Laboratories (U.S.), and Charles River Laboratories (U.S.).

FOR MORE DETAILS - @ https://www.marketresearchfuture.com/reports/bio-process-technology-market-2095 

Monoclonal antibody therapy Market Covering Growth Inclinations & Development Strategies Until 2022

 Market Overview:

Monoclonal antibodies are laboratory-produced antibodies structured to be the substitute of natural antibodies which can enhance or mimic the immune system's attack on harmful cells. Monoclonal antibody therapy is a type of immunotherapy which requires monoclonal antibodies to bind specifically to certain type of cells and proteins which stimulates the immune system to attack those cells. Currently, it is possible to produce monoclonal antibodies specific to any extracellular target and research is being carried out to amplify the application scope of the monoclonal antibodies in different areas of medical science. Globally, the market for monoclonal antibody therapy is growing rapidly and it is expected to grow at the rate of about XX% from 2016 to 2022.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/2089 

The global monoclonal antibody therapy market has been evaluated as rapidly growing market and it is expected that the market will continue to grow similarly in the near future. Antibodies are an important part of the immune system.  Generally, our body creates antibodies in response to an antigen entering the body.  These antibodies attach to the antigen in order to mark it as harmful which is then destroyed by the body's immune system. Monoclonal Antibodies are the antibodies produced in the laboratory which can mimic the function of a normal antibody to attack the antigen. However, monoclonal antibodies are engineered in such a way that they identify and attach to the mono-specific targeted antigen on the surface of the cancer cell or any other foreign cell. It is often referred to as a targeted immunotherapy. Monoclonal antibodies identify and destroy the tumor cells without causing any harm to the normal healthy cells of the body. The major application of the monoclonal antibody therapy is the treatment of the cancer. Having said that, Monoclonal antibody therapy can only be done for the cancers in which the antigens have been identified so far. Some of the common monoclonal antibodies are Alemtuzumab, Rituximab, Trastuzumab, Gemtuzumab ozogamicin, Ibritumomab Tioxetan.

According to WHO, the world will witness more than 70% rise in the number of cancer patients in the next few years, out of which maximum number of patients will be from the Asia, Africa and South America region. There has been extensive research going on to develop the new monoclonal antibodies and drugs in order to treat the wide range of disorders with minimum side effects. The sudden rise in the number of cancer cases is likely to propel the growth of the monoclonal antibody therapy market in the near future. Moreover the commercialization of the newly developed monoclonal antibodies and drugs will give a boost to the monoclonal antibody therapy market. On the other hand, lack of awareness about the technology in the developing nations and the limited healthcare expenditure and low affordability of such expensive treatments in the low income economies is expected to hamper the growth of the monoclonal antibody market.

Global Monoclonal Antibody Therapy Market Players:

There are plenty of large and small market players which operate in this market all over the globe. The major participants of this market are AbbVie Inc., Amgen Inc., Bayer AG,        Biogen Inc., Bristol–Myers Squibb Company, F. Hoffmann-La Roche Ltd., GenScript, GlaxoSmithKline Plc., Johnson & Johnson, Merck KGaA, Novartis AG, Pfizer Inc., Sanofi, Sigma-Aldrich Co. LLC, and others.

Regional Analysis:

Depending on geographic region, monoclonal antibody therapy market is segmented into four key regions:  America, Europe, Asia-Pacific, and Middle East & Africa. Globally, America is the largest market for monoclonal antibody therapy. North American region is the leading market in the America region. Europe is the second-largest market globally for monoclonal antibody therapy which is expected to continue its growth in the near future. Asia pacific region is expected to be fastest growing region in monoclonal antibody therapy market.

Segmentation:

Monoclonal antibody therapy market has been segmented on the basis of source which comprises of recombinant, chimeric, humanized, human, and other.  On the basis of application, market is segmented into diagnostic test, analytical and chemical uses, cancer treatment, autoimmune diseases, hematological disorders, and others. On the basis of end user, market is segmented into hospitals, clinic, research laboratories and others.

FOR MORE DETAILS - @ https://www.marketresearchfuture.com/reports/monoclonal-antibody-therapy-market-2089 

Digital Pathology Market Value Share, Supply Demand, Share And Value Chain analysis to 2023

 Market Overview:

Digital Pathology comprises an array of equipment capable of capturing, analyzing, interpreting, and managing digital information gained from slides. The technology is gaining focus rapidly thanks to its wide application in tissue-based research, human pathology, and drug development. Global Digital Pathology Market is expected to register a CAGR of 13.04% during the forecast period from 2018 to 2023 and expected to reach USD 8,305.6 MN by 2023.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/1955 

With the evolution of information technology in the past few years, a rapid change has being observed in the practice of pathology. Various novel techniques have been implemented, primarily in the form of digital imaging and Telepathology (TP). Digital pathology is a branch which can be defined as the electronic capture, management, analysis and distribution of gross or microscopic specimens. It encompasses the use of digital imaging as well as TP. Digital pathology has a wide spectrum of applications that includes primary diagnosis, intraoperative diagnosis, consultation, quality assurance, archiving, research and academic studies. This technique helps in speeding up the process of diagnosis and further treatment. It also helps in research procedures by offering an easy access to the previously stored digital information. As per the Royal College of Pathologists, in the UK alone pathologists carry out 121,000 autopsies each year which has supported the market growth.

The global digital pathology market is growing with the rapid pace; mainly due technologically advanced diagnostic tools for the chronic diseases such as cancer has upsurged the demand for digital pathology. According to a recent study report published by the Market Research Future, The global digital pathology market is booming and expected to gain prominence over the forecast period growing rapidly. The market is forecasted to demonstrate a spectacular growth by 2022, surpassing its previous growth records in terms of value with a striking CAGR during the anticipated period (2017 – 2022).

The market is expected grow with the same trends during the forecast period. The major drivers will be rapid technological advancements in digital pathology system such as advancements in digital imaging, robotic light microscopy, and multiple fiber optic communications among others. Moreover, growing prevalence of chronic conditions, that has expected to uplift the demand for digital pathology in order to improve existing patient diagnostic imaging measures and reduce high cost associated with the traditional diagnostics methods. For instance, as per National Pathology Programme, nearly 800 million tests are being performed annually which is equal to 14 for each person in England and Wales. Additionally, increasing R&D applications of static and dynamic systems is fostering the market growth of digital pathology market.

Global Digital Pathology Market   - Competitive Analysis

The market for digital pathology is characterised by the presence of several well-established and small players, the global market of digital pathology appears to be highly competitive and fragmented. Global players are increasingly expanding their footprint in the emerging nations, making it putting pressure on the regional players, especially in terms of features such as type, product portfolios, and pricing. The market is witnessing intensified competition which is expected to get more intensified further during the forecast period. Well established players are entering into mergers & acquisitions, collaboration, partnership, expansion, and product launch in order to gain competitive advantage in this market and to maintain their market position.  

Companies like Leica Biosystems; Hamamatsu Photonics, Inc.; and Olympus Corporation are increasingly adopting extensive collaborative strategies to gain more profits and capturing new markets. For instance, in March 2017, Leica Biosystems entered into a strategic partnership with Leeds Hospital to improve productivity and workflow.

Key participants like Royal Philips has acquired the Irish PathXL, one of the largest pathology, image-based analysis firms in order to develop integrated tools targeting applications in computational biology, workflow solutions, education, and image analytics. In addition, these key activities the companies are aiming towards supporting the gradual transition of medical institutions present across the globe from the conventional pathology systems to digital pathology systems.

Thus, we can say that these competitive developments will further enable pathologists to perform high-throughput analysis of clinical image datasets that are diverse in nature and expedite improvement in the diagnosis quality, thereby presenting a potential for adoption new ad improved therapies to enhance patient health outcomes.

microDimensions GmbH (Germany), Mikroscan Technologies, Inc. (U.S.), Q2 Solutions (U.S.), Omnyx, LLC (U.S.), GE Healthcare (UK), Philips Healthcare (U.S.), Huron Digital Pathology Inc. (Canada), ViewsIQ Inc. (Canada), 3DHISTECH Ltd (Hungary) Apollo Enterprise Imaging Corp. (U.S.), Xifin Inc. (U.S.), Definiens (Germany) and others. are some of the prominent players at the forefront of competition in the Global Digital Pathology Market and are profiled in MRFR Analysis. 

FOR MORE DETAILS - @ https://www.marketresearchfuture.com/reports/digital-pathology-market-1955

Malignant Lymphoma Market 2019 - Opportunity, Driving Trends And Deep Study 2022

 Market Overview:

LASIK Eye Surgery also known as Myopia has gained a lot of recognition over the last few years owing to the ample benefits it offers along with the guaranteed success rate of almost 96%. Besides, this surgery promises chances to get rid of spectacles and contact lenses for life. Which is why many are opting to undergo this surgery to get their eye sight rectified. Resultantly, the market for LASIK Eye Surgery is garnering exponential traction on the global platform.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/1723 

Acknowledging the kind of growth the LASIK Eye Surgery market is witnessing currently and the growth prospects the market is demonstrating globally; Market Research Future (MRFR) recently published a brilliant study report giving out the complete market insights up till 2022. In its report MRFR asserts that the global LASIK Eye Surgery market is projected to grow exponentially by 2022, registering 6.5% CAGR throughout the forecast period (2017 – 2022).

In addition, other factors that predominantly drive the market growth include growing population and urbanization that has introduced many devices like mobile phone and unhealthy lifestyle. Which resultantly has increased prevalence of myopia, hyperopia astigmatism and several other vision problems. To rectify these issues people are increasingly resolving to LASIK Surgery for its advantages.

Moreover, some LASIK companies work with insurance providers and certain large employers to provide LASIK discounts to their employees and CareCredit (a healthcare credit card) that covers all medical expenses, including LASIK eye surgery. These easy payment plans offered by LASIK companies fosters the market growth making LASIK as the most preferred surgery.

However, this revolutionary technique has a minor downside that is, its technical complexity. Which sometimes presents challenges to the doctors performing this surgery, while creating the flap. This can result in to damaging the vision permanently. But the good news is LASIK can rarely cause loss of "best" vision.

Worldwide LASIK Eye Surgery Market - Competitive Landscape

The market of LASIK Eye Surgery appears to be fiercely competitive & fragmented owing to the presence of numerous matured & small key players accounting for a substantial market share. These market players try to gain competitive advantage through strategic partnership, acquisition, expansion, collaboration, product & technology launch. They invest heavily in the R&D to develop a technology that is completely on a different level compared to their competition. 

Industry, Innovation & Related News

February 27, 2018 – The LASIK Vision Institute (US), a leading provider of LASIK surgery, announced opening of a new center in Duluth, Georgia. The new facility will be featuring topography-guided LASIK technology, the latest in FDA-approved technology for this procedure. 

February 14, 2018 - The Omaha Eye & Laser Institute (US) a Pioneer in LASIK & other Laser surgeries & of Eye Care announced that now the institute is also specialized in iLASIK (Customized Bladeless)   - considered as one of the most advanced forms of fully-customized , Lasik Laser Vision Correction

February 20, 2018 - Lehigh Valley Center (US) one of the leading eye care centre & LASIK Specialists announced the availability of IntraLase/Bladeless LASIK Eye Surgery.

Worldwide LASIK Eye Surgery Market - Segments

For an easy grasp and enhanced understanding; the report LASIK Eye Surgery Market is segmented in to 4 Key dynamics

By Vision Errors : Comprises - Hyperopia, Myopia, Astigmatism and other.

By Types             : Wavefront-guided, Wavefront optimized, topography guided and all lasers.

By End Users      : Hospitals, eye care clinic, LASIK center and other.

By Regions                    :  North America, Europe, APAC and Rest of the World.

Worldwide LASIK Eye Surgery Market – Geographical Analysis

North America market dominates the global LASIK eye surgery market with the significant market share. The market is further expected to reach astronomical amounts growing at a substantial CAGR throughout the forecast period (2016-2022).

Europe & Asia Pacific is the second & third largest market respectively in the global LASIK eye surgery market. Expected to be a fastest growing market Asia pacific region is estimated to grow rapidly over the projected period.

Key Players:

Nidek, Inc., AMO Manufacturing USA LLC, Abbott Inc., Carl Zeiss, Inc., Alcon Laboratories, Inc., Lasersight Technologies. Inc. and Bausch & Lomb Surgical, Inc. are some of the leaders driving the Global LASIK Eye Surgery Market. Profiling those in its analysis MRFR finds out their strategies placing them at the forefront of completion.

FOR MORE DETAILS - @ https://www.marketresearchfuture.com/reports/lasik-eye-surgery-market-1774 

LASIK Eye Surgery Market Growth And Restrain Factors Analysis By 2022

 Market Overview:

LASIK Eye Surgery also known as Myopia has gained a lot of recognition over the last few years owing to the ample benefits it offers along with the guaranteed success rate of almost 96%. Besides, this surgery promises chances to get rid of spectacles and contact lenses for life. Which is why many are opting to undergo this surgery to get their eye sight rectified. Resultantly, the market for LASIK Eye Surgery is garnering exponential traction on the global platform.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/1723 

Acknowledging the kind of growth the LASIK Eye Surgery market is witnessing currently and the growth prospects the market is demonstrating globally; Market Research Future (MRFR) recently published a brilliant study report giving out the complete market insights up till 2022. In its report MRFR asserts that the global LASIK Eye Surgery market is projected to grow exponentially by 2022, registering 6.5% CAGR throughout the forecast period (2017 – 2022).

In addition, other factors that predominantly drive the market growth include growing population and urbanization that has introduced many devices like mobile phone and unhealthy lifestyle. Which resultantly has increased prevalence of myopia, hyperopia astigmatism and several other vision problems. To rectify these issues people are increasingly resolving to LASIK Surgery for its advantages.

Moreover, some LASIK companies work with insurance providers and certain large employers to provide LASIK discounts to their employees and CareCredit (a healthcare credit card) that covers all medical expenses, including LASIK eye surgery. These easy payment plans offered by LASIK companies fosters the market growth making LASIK as the most preferred surgery.

However, this revolutionary technique has a minor downside that is, its technical complexity. Which sometimes presents challenges to the doctors performing this surgery, while creating the flap. This can result in to damaging the vision permanently. But the good news is LASIK can rarely cause loss of "best" vision.

Worldwide LASIK Eye Surgery Market - Competitive Landscape

The market of LASIK Eye Surgery appears to be fiercely competitive & fragmented owing to the presence of numerous matured & small key players accounting for a substantial market share. These market players try to gain competitive advantage through strategic partnership, acquisition, expansion, collaboration, product & technology launch. They invest heavily in the R&D to develop a technology that is completely on a different level compared to their competition. 

Industry, Innovation & Related News

February 27, 2018 – The LASIK Vision Institute (US), a leading provider of LASIK surgery, announced opening of a new center in Duluth, Georgia. The new facility will be featuring topography-guided LASIK technology, the latest in FDA-approved technology for this procedure. 

February 14, 2018 - The Omaha Eye & Laser Institute (US) a Pioneer in LASIK & other Laser surgeries & of Eye Care announced that now the institute is also specialized in iLASIK (Customized Bladeless)   - considered as one of the most advanced forms of fully-customized , Lasik Laser Vision Correction

February 20, 2018 - Lehigh Valley Center (US) one of the leading eye care centre & LASIK Specialists announced the availability of IntraLase/Bladeless LASIK Eye Surgery.

Worldwide LASIK Eye Surgery Market - Segments

For an easy grasp and enhanced understanding; the report LASIK Eye Surgery Market is segmented in to 4 Key dynamics

By Vision Errors : Comprises - Hyperopia, Myopia, Astigmatism and other.

By Types             : Wavefront-guided, Wavefront optimized, topography guided and all lasers.

By End Users      : Hospitals, eye care clinic, LASIK center and other.

By Regions                    :  North America, Europe, APAC and Rest of the World.

Worldwide LASIK Eye Surgery Market – Geographical Analysis

North America market dominates the global LASIK eye surgery market with the significant market share. The market is further expected to reach astronomical amounts growing at a substantial CAGR throughout the forecast period (2016-2022).

Europe & Asia Pacific is the second & third largest market respectively in the global LASIK eye surgery market. Expected to be a fastest growing market Asia pacific region is estimated to grow rapidly over the projected period.

Key Players:

Nidek, Inc., AMO Manufacturing USA LLC, Abbott Inc., Carl Zeiss, Inc., Alcon Laboratories, Inc., Lasersight Technologies. Inc. and Bausch & Lomb Surgical, Inc. are some of the leaders driving the Global LASIK Eye Surgery Market. Profiling those in its analysis MRFR finds out their strategies placing them at the forefront of completion.

FOR MORE DETAILS - @ https://www.marketresearchfuture.com/reports/lasik-eye-surgery-market-1774 

Astigmatism Market Segmentation Detailed Study With Forecast Up To 2022

 Market Overview:

Astigmatism is the situation in which patient suffered with blurred vision. It is a refractive error condition in which eyes not able to focus light evenly onto the retina. Normally astigmatism is occurring with condition like myopia and hyperopia, these both condition causes refractive errors because they affect how the eyes bend or "refract" light. It can be diagnosed by eye exam, and treatment depend upon the condition of astigmatism. There are two treatments are available for the common levels of astigmatism that are corrective lenses and refractive surgery. According to American Academy of Ophthalmology, in the United States 1 in 3 people may suffer with astigmatism and it may occur in combination with near- or farsightedness. Also, according to a report published by the Centers for Disease Control and Prevention in 2015, Around 11 million population of Americas of age 12 years and above improve their vision through proper refractive correction and more than 3.3 million Americans aged 40 years and older are either legally blind or are with low vision.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/1723 

Global Astigmatism Market – Overview

The global astigmatism market is showing the significant growth; mainly due to increase in the ageing population, eye injury, eye disease, and surgery. Companies are showing much interest toward the astigmatism market, as they feel there are huge opportunities and gaps between the market demand and supply of effective treatments. Thus, companies are showing more interest in research and development activities for introducing best treatment that meets the requirement of market. The development has been made by Novartis AG in 2017, Alcon is the division of Novartis and consider as a global leader in eye care, introduce AcrySof IQ PanOptix Toric presbyopia- and astigmatism-correcting intraocular lens (IOL) for patients with pre-existing corneal astigmatism undergoing cataract surgery. Also, in 2018, Johnson & Johnson Vision announced the launch of expanded parameters for 1-DAY ACUVUE MOIST Brand Contact Lenses for astigmatism in the United States. These inventions help companies to meet the requirement of the market and maximize the profit share across the globe. Moreover, in 2017, Bausch & Lomb Incorporated division of Valeant Pharmaceuticals International, Inc. introduce Biotrue ONEday for Astigmatism daily disposable contact lenses in 20 countries of Europe. Novartis AG and Johnson & Johnson are trying to feel the gap along with market players such as SeaVision USA, Bausch & Lomb Incorporated, CooperVision, Inc., Orion Vision Group.

Novartis AG (Switzerland), SeaVision USA (U.S.), Johnson & Johnson Services, Inc. (U.S.), Bausch & Lomb Incorporated (U.S.), CooperVision, Inc. (U.S.), Orion Vision Group (Georgia) are some of the leading players at the cutting edge of the competition in the market of astigmatism, globally.

Global Astigmatism Market   - Regional Analysis

The market of astigmatism is much higher in the Americas region. There are several factors for tremendous growth of the astigmatism market in this region such as growing ageing population, presence of major market players, and increasing awareness about astigmatism. According to reports published by the Centers for Disease Control and Prevention in 2015, Around 1.8 million Americans aged 40 years and above are affected by AMD and an additional 7.3 million with large drusen are at substantial risk of developing AMD.

Europe is also considering the huge market for astigmatism players, owing to present of the huge ageing population. Moreover, the population within the reason are more aware about the healthcare in comparison to another region like Asia Pacific and The Middle East and Africa.

Asia Pacific and the Middle East and Africa region are considering the big opportunity for the market players owing to the presence of the high patient population. Whereas country like India and china of Asia Pacific region are considering fastest growing region owing to the presence of active government towards health care. These countries are open to adopt new treatment from developing countries in order to improve the quality of life for their citizen. Japan is a well-developed country and have well established healthcare system and technology, whereas developing countries are still focusing on new technology, which lead to increase in the demand for various astigmatism treatment. Most of the countries of these regions such as India and China are investing more into research and development activity for introducing better treatment at nominal price.

FOR MORE DETAILS - @ https://www.marketresearchfuture.com/reports/astigmatism-market-1734 

Cystic Acne Market 2019–By Identifying The Key Market Segments And Key Players Holding Market Share

 

Market Highlights

Cystic acne is majorly treated with topical medications, drainage & extraction procedure, and laser therapy, and microdermabrasion. Increasing awareness and prevalence of population affected by acne are boosting the demand for a laser treatment that has driven the growth of laser devices and medications for the cystic Acne. The cystic acne market has been a growing market and it has been expected that the market is likely to touch high growth figures.

According to The National Center for Biotechnology Information, in 2015, around 9.4% of the global population is affected by acne and making it the 8th most prevalent disease worldwide. Acne often causes significant physical and psychological problems such as permanent scarring, poor self-image, depression, and anxiety.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/1723 

The market is expected to flourish in developing regions of Asia Pacific owing to the rising patient population with cystic acne. Increasing prevalence of cystic acne, rising demand for better treatment, increasing investment in the biotechnology and pharmaceutical industries for research and development are driving the growth of the market. Moreover, increasing government support for research & development, changing lifestyle, and rapidly developing technology are expected to fuel the market growth during the forecast period. However, lack of effective treatment in the market may hinder the market growth during the forecast period.

The global cystic acne market is expected to grow at a CAGR of 10% during the forecast period 2017-2023.

Regional Analysis

The Americas dominate the global cystic acne market owing to the presence of a huge patient population suffering from a skin condition, high health care spending, and increasing government support for research & development. According to American Academy of Dermatology, acne is affecting around 50 million Americans annually and around 20 million American have acne badly enough to cause scars.

Europe holds the second largest share of the global cystic acne market as a result of increasing focus of various government agencies on the treatment of diseases. Moreover, the growing public awareness about cystic acne is likely to boost the European market.

The Asia Pacific is the fastest growing market across the globe. Moreover, rapidly developing the economy, increasing healthcare expenditure, and the government’s initiatives for research & development are projected to drive the market in China and India.

The Middle East and Africa hold the least share of the global market due to limited availability of medical facilities.

Segmentation

The global cystic acne market is segmented on the basis of causes, long-term effects, treatment type and end user. On the basis of the causes, it is segmented into hormonal imbalances, occlusive skin products, drugs/chemical side effects, and others. On the basis of the long-term effects, it is segmented into ice pick scars, larger pits on the skin, shallow depressions, hypertrophic scarring, and others. On the basis of the treatment type, it is segmented into topical medications, drainage & extraction procedure, laser therapy, microdermabrasion, and others. On the basis of the end user, it is segmented into hospitals, clinics, research laboratories, and others.

Key Players

Some of the key players in this market are GlaxoSmithKline plc (U.K), Pfizer Inc. (U.S.), Abbott Laboratories (U.S.), Hexal AG (Germany), F. Hoffmann-La Roche Ltd (Switzerland), Alma Lasers Inc. (Israel), Bristol-Myers Squibb Company (U.S.), GE Healthcare (U.K), National Biological Corp. (U.S.), Herbert Waldmann GmbH & Co. KG (Germany), Sylvan Company (U.S.) and DUSA Pharmaceuticals Inc. (U.S.).

FOR MORE DETAILS - @ https://www.marketresearchfuture.com/reports/cystic-acne-market-1723